This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions

Example PlanDefinition/opioidcds-08 (Narrative)

Clinical Decision Support Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: No defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format.

Generated Narrative: PlanDefinition

Resource PlanDefinition "opioidcds-08"

StructureDefinition Work Group: cds

identifier: URI/urn:oid:2.16.840.1.113883.4.642.11.10, cdc-opioid-guidance (use: OFFICIAL)

version: 0.1.0

name: Cdcopioid08

title: CDC Opioid Prescribing Guideline Recommendation #8

type: ECA Rule (PlanDefinitionType#eca-rule)

status: draft

date: 2018-03-19

publisher: HL7 International / Clinical Decision Support


description: Clinicians should incorporate into the management plan strategies to mitigate risk, including considering offering naloxone when factors that increase risk for opioid overdose, such as history of overdose, history of substance use disorder, higher opioid dosages (≥50 MME/day), or concurrent benzodiazepine use, are present.


*Clinical Focus (Details: http://terminology.hl7.org/CodeSystem/usage-context-type code focus = 'Clinical Focus', stated as 'Clinical Focus')Medication requested (situation) (SNOMED CT#182888003)
*Clinical Focus (Details: http://terminology.hl7.org/CodeSystem/usage-context-type code focus = 'Clinical Focus', stated as 'Clinical Focus')Chronic pain (finding) (SNOMED CT#82423001)

jurisdiction: United States of America (ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code#US)

purpose: CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended to improve communication between providers and patients about the risks and benefits of opioid therapy for chronic pain, improve the safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid therapy, including opioid use disorder and overdose. The Guideline is not intended for patients who are in active cancer treatment, palliative care, or end-of-life care.

usage: Before starting and periodically during continuation of opioid therapy, clinicians should evaluate risk factors for opioid-related harms.

copyright: © CDC 2016+.

topic: Opioid Prescribing ()

author: Kensaku Kawamoto, MD, PhD, MHS: , Bryn Rhodes: , Floyd Eisenberg, MD, MPH: , Robert McClure, MD, MPH:


type: documentation

display: CDC guideline for prescribing opioids for chronic pain



type: documentation

display: MME Conversion Tables


library: http://example.org/fhir/Library/opioidcds-recommendation-08


Strength of recommendation: Strong (StrengthOfRecommendationRating#strong)

Quality of evidence: Low quality (QualityOfEvidenceRating#low)

title: Existing patient exhibits risk factors for opioid-related harms.

description: Checking if the trigger prescription meets the inclusion criteria for recommendation #8 workflow.






kind: applicability


*Check whether the existing patient exhibits risk factors for opioid-related harms, such as concurrent use with benzodiazepine, a history of substance abuse, and/or an average MME greater than 50 mg/day.text/cqlInclusion Criteria

groupingBehavior: visual-group

selectionBehavior: exactly-one


path: action.description


*text/cqlGet Detail


path: action.title


*text/cqlGet Summary


path: action.extension


*text/cqlGet Indicator


*Will offer Naloxone instead
*Risk of overdose carefully considered and outweighed by benefit; snooze 3 mo
*N/A - see comment; snooze 3 mo



Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.